FLAG Therapeutics Announces Encouraging Preclinical Data from Studies of FLAG-003 for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
July 16, 2024 09:00 ET
|
Flag Therapeutics, Inc.
FLAG Therapeutics Announces Encouraging Preclinical Data from Studies of FLAG-003 for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
Humacyte Board of Directors Strengthened with Addition of John P. Bamforth and Keith Anthony Jones
July 16, 2024 08:00 ET
|
Humacyte, Inc
DURHAM, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissues at...
Velocity appoints ex-IQVIA and Science 37 Executive Mike Zaranek as CFO
July 16, 2024 07:04 ET
|
Velocity Clinical Research, Inc.
DURHAM, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, today announces it has appointed Mike Zaranek as Chief...
Milestone Pharmaceuticals Refreshes Board of Directors
July 15, 2024 08:00 ET
|
Milestone Pharmaceuticals Inc.
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 ...
Atsena Therapeutics Appoints Joseph S. Zakrzewski as Board Chair
July 15, 2024 07:30 ET
|
Atsena Therapeutics
DURHAM, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent...
Fortrea Appoints Robert Parks as Chief Accounting Officer
July 11, 2024 08:00 ET
|
Fortrea Holdings Inc
DURHAM, N.C., July 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Robert “Bobby” Parks has been appointed as chief...
GeneType to Enter Canadian and New Zealand Markets
July 09, 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType to Enter Canadian and New Zealand Markets
ORLADEYO® (berotralstat) Approved in Peru
July 09, 2024 07:00 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the General Directorate of Medicines, Supplies and Drugs (DIGEMID)...
Kriya Appoints Scientific Co-Founder J. Fraser Wright, Ph.D., as Chief Gene Therapy Officer
July 08, 2024 09:05 ET
|
Kriya Therapeutics, Inc.
– Dr. Wright has three decades of experience in the research and development of viral vectors and has been involved in the development of multiple approved gene therapies globally – PALO ALTO, Calif....
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 05, 2024 16:05 ET
|
Chimerix, Inc.
DURHAM, N.C., July 05, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on July 1, 2024, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to...